Capstar Special Purpose Acquisition Corp.
Status: Deal Closed
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $276.00M |
|---|---|
| IPO Date | Jul 2, 2020 |
| CEO | R. Steven Hicks |
| Left Lead | Citigroup |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
General
Consumer, Healthcare or TMT |
| IPO Geography | Global |
| Target Company | Gelesis |
| Deal Announced | Jul 19, 2021 |
| Deal Size, $M | $964.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings | www.sec.gov |
| Approval Vote | Jan 11, 2022 |
| Amendment Vote | TBD |
| Closing Date | Jan 13, 2022 |
Formerly CPSR
GLSHQ
GLS/W
| Price | $0.00 |
|---|---|
| Last closing price | $0.00 |
| H/L, today | $0.00 / $0.00 |
| Volume, today | 2,876 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Capstar Special Purpose Acquisition Corp.:
- Structure and cap table
- 5 directors & officers
- 27 filings and events
- 3 underwriters
- 5 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| R. Steven Hicks | 70 | Chairman, CEO and CFO |
| Rodrigo de la Torre | 39 | Director |
| Kathryn Cavanaugh | 46 | Director |
| John Ghiselli | 56 | Director |
| James Whittenburg | 48 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Deal
Sign in to view merger details and deal financials.